Epidiolex Almost Didn't Get Proprietary Name Because Of Confusion With OTC Pedia-Lax

US FDA's lead name reviewer laid out slew of reasons why the two names could be confused; her bosses agreed with the individual points, but felt that mitigation measures to avoid confusion were sufficient when considered holistically. 

More from Drug Review Profiles

More from Product Reviews